Pelitinib
CAS No. 257933-82-7
Pelitinib( EKB-569 | WAY-EKB 569 | EKB569 | EKB 569 )
Catalog No. M13779 CAS No. 257933-82-7
A potent, selective, orally active, irreversible inhibitor of EGFR with IC50 of 80 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 39 | In Stock |
|
10MG | 55 | In Stock |
|
25MG | 96 | In Stock |
|
50MG | 120 | In Stock |
|
100MG | 178 | In Stock |
|
500MG | 441 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePelitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, orally active, irreversible inhibitor of EGFR with IC50 of 80 nM.
-
DescriptionA potent, selective, orally active, irreversible inhibitor of EGFR with IC50 of 80 nM; inhibits autophosphorylation of the cytoplasmic domain of HER-2 with IC50 of 1.23 uM; shows 1-3 orders of magnitude higher IC50 value for Src, Cdk4, c-Met, Raf, and MEK/ERK; inhibits proliferation in NHEK, A431, and MDA-468 cells (IC50= 61, 125, and 260 nM, respectively); potently inhibits the EGFR phosphorylation in A431 xenografts, suppresses tumorigenesis in APCMin/+ mice.Lung Cancer Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsEKB-569 | WAY-EKB 569 | EKB569 | EKB 569
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR|HER2/ErbB2|MEK|Raf|Src
-
Research AreaCancer
-
IndicationLung Cancer
Chemical Information
-
CAS Number257933-82-7
-
Formula Weight467.9231
-
Molecular FormulaC24H23ClFN5O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 16 mg/mL
-
SMILESO=C(NC1=C(OCC)C=C2N=CC(C#N)=C(NC3=CC=C(F)C(Cl)=C3)C2=C1)/C=C/CN(C)C
-
Chemical Name2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-, (2E)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wissner A, et al. J Med Chem. 2003 Jan 2;46(1):49-63.
2. Nunes M, et al. Mol Cancer Ther. 2004 Jan;3(1):21-7.
3. Torrance CJ, et al. Nat Med. 2000 Sep;6(9):1024-8.
molnova catalog
related products
-
Simotinib
Simotinib (SIM-6802) is a novel potent EGFR inhibitor for treatment of NSCLC.
-
PF 6274484
PF 6274484, a high affinity, irreversible covalent inhibitor of EGFR kinase with Ki of 0.14 nM.
-
WHI-P154
WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation.